etrasimod arginine api 02
3 Inquiries
1206123-37-6
Pharmaceutical Grade
99%
Shanghai
15kg/Cardboard Drum
2023-05-25
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Etrasimod
Other Name:Etrasimod;(R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid;APD-334;APD 334;CS-2445;Etrasimod(APD334);APD334; APD-334; APD 334; ETRASIMOD;Cyclopent[b]indole-3-acetic acid, 7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydro-, (3R)-;Etrasimod,APD-334,LPL Receptor,Inhibitor,inhibit,APD 334,Lysophospholipid Receptor
CAS No.:1206123-37-6
Molecular Formula:C26H26F3NO3
InChIKeys:MVGWUTBTXDYMND-QGZVFWFLSA-N
Molecular Weight:457.48
Exact Mass:457.186
Color/Form:White to khaki
Categories:
Characteristics-
PSA:
62.32
XLogP3:6.9278
Density:1.326±0.06 g/cm3(Predicted)
Boiling Point:621.4±50.0 °C(Predicted)
PKA:4.61±0.10(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Location:
Building 4, Juanhu Int. Sci & Innovation Park, No. 500, Shuiyueting East Road, Xishi Street, Haining, Jiaxing, Zhejiang
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
20
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
201-300
-
Year of Establishment:
2021
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
Etrasimod
50 KG Jun 3, 2024
Pakistan
ETRASIMOD
30 G Apr 16, 2025 
India
Etrasimod
0.5 G Jan 17, 2024 Post an enquiry for this product